Followers | 14 |
Posts | 909 |
Boards Moderated | 0 |
Alias Born | 09/29/2016 |
Sunday, February 12, 2017 3:15:42 PM
Six Healthcare Stocks with Nice Upside Potential
Recent ICLR News
- ICON Announces Pricing of USD 2 Billion Notes • Business Wire • 04/30/2024 08:55:00 PM
- ICON Reports First Quarter 2024 Results • Business Wire • 04/24/2024 08:15:00 PM
- ICON Announces CFO Transition • Business Wire • 04/03/2024 08:15:00 PM
- ICON plc Schedules First Quarter 2024 Earnings Conference Call • Business Wire • 03/25/2024 08:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:37:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 11:10:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:38:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:25:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:16:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:05:43 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/26/2024 09:31:28 PM
- ICON plc to Present at Upcoming Investor Conferences • Business Wire • 02/26/2024 09:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 09:14:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 09:13:36 PM
- ICON Reports Fourth Quarter and Full Year 2023 Results • Business Wire • 02/21/2024 09:15:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/30/2024 05:11:57 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2024 11:15:06 AM
- ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call • Business Wire • 01/30/2024 11:00:00 AM
- New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment • Business Wire • 01/24/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/09/2024 01:15:06 PM
- ICON Issues Financial Guidance for Full Year 2024 • Business Wire • 01/09/2024 01:00:00 PM
- Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON • Business Wire • 01/08/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/04/2024 12:15:31 PM
- ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/04/2024 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM